Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/biote Corp./ SCHEDULE 13G/A

SEC Filing · SCHEDULE 13G/A

biote Corp.

BTMDNASDAQEQUITYCurrent

SEC Filing

Filed Sep 18, 2026Accepted Sep 18, 2026, 9:03 AM EDTCIK 1819253Accession 0001820959-26-000001
View company →Permanent SEC source ↗
Share

Company context

Biote advances the healthspan of our Practitioners’ patients by providing innovative hormone optimization and healthy aging solutions. Through our network of Biote certified providers, we collaborate with leading clinicians to restore vitality and promote vibrant aging.

Current securities

BTMDNASDAQ · EQUITY · Current
Historical securities (6)
BTMDWNASDAQ · WARRANT · Historical · closed Jul 19, 2022BTMDWNASDAQ · WARRANT · Historical · closed Jul 10, 2023BTMDWOTC · WARRANT · Historical · closed Aug 28, 2022HYACNASDAQ · EQUITY · Historical · closed May 27, 2022HYACUNASDAQ · UNIT · Historical · closed May 27, 2022HYACWNASDAQ · WARRANT · Historical · closed May 27, 2022

Recent company filings

  1. SCHEDULE 13G/A filingSep 1, 2026
  2. SCHEDULE 13G filingAug 28, 2026
  3. 4 filingAug 12, 2026
  4. 10-Q filingAug 7, 2026
  5. Results of Operations and Financial ConditionAug 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗